These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 3089650
1. Natural killer activity in patients with acute viral hepatitis. Chemello L, Mondelli M, Bortolotti F, Schiavon E, Pontisso P, Alberti A, Rondanelli EG, Realdi G. Clin Exp Immunol; 1986 Apr; 64(1):59-64. PubMed ID: 3089650 [Abstract] [Full Text] [Related]
2. Interleukin-2 and natural killer activity in acute type B hepatitis. Echevarria S, Casafont F, Miera M, Lozano JL, de la Cruz F, San Miguel G, Pons Romero F. Hepatogastroenterology; 1991 Aug; 38(4):307-10. PubMed ID: 1937376 [Abstract] [Full Text] [Related]
3. Alterations in natural killer cells and natural killer T cells during acute viral hepatitis E. Srivastava R, Aggarwal R, Bhagat MR, Chowdhury A, Naik S. J Viral Hepat; 2008 Dec; 15(12):910-6. PubMed ID: 18673427 [Abstract] [Full Text] [Related]
4. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts. Baba M, Hasegawa H, Nakayabu M, Fukai K, Suzuki S. J Clin Lab Immunol; 1993 Dec; 40(2):47-60. PubMed ID: 7932628 [Abstract] [Full Text] [Related]
5. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Oliviero B, Varchetta S, Paudice E, Michelone G, Zaramella M, Mavilio D, De Filippi F, Bruno S, Mondelli MU. Gastroenterology; 2009 Sep; 137(3):1151-60, 1160.e1-7. PubMed ID: 19470388 [Abstract] [Full Text] [Related]
6. Natural killer-cell cytotoxicity in HIV-positive and HIV-negative patients with and without severe course of hepatitis B virus infection. Morsica G, Tasca S, Biswas P, Galli A, Malnati M, Paties C, Marinelli M, Bagaglio S, Lazzarin A, Fortis C. Scand J Immunol; 2005 Sep; 62(3):318-24. PubMed ID: 16179020 [Abstract] [Full Text] [Related]
7. Interferon responsiveness of natural killer cells in type I human diabetes. Negishi K, Gupta S, Chandy KG, Waldeck N, Kershnar A, Buckingham B, Charles MA. Diabetes Res; 1988 Jan; 7(1):49-52. PubMed ID: 3402165 [Abstract] [Full Text] [Related]
8. The immunologic staging of chronic active hepatitis B patients in Hawaii. Ching N, Lumeng J, Pon E, Ching CY. Hawaii Med J; 1994 Feb; 53(2):44-5, 49. PubMed ID: 7514583 [Abstract] [Full Text] [Related]
9. [The interferon system and natural cytotoxicity functions in patients with acute viral hepatitis A and B]. Kaverina OV, Chernova LG, Fabrikov AP, Malinovskaia VV, Kasimova NB, Karpenko SF, Sluvko EI, Cherenova OP. Ter Arkh; 1994 Feb; 66(2):7-9. PubMed ID: 7512755 [No Abstract] [Full Text] [Related]
11. [Effect of interferon on clinico-laboratory indicators in patients with acute viral hepatitis B]. Pokrovskiĭ VI, Zmyzgova AV, Matveeva SM, Saltykov VP, Soibnazarov ISh. Ter Arkh; 1986 Feb; 58(10):29-32. PubMed ID: 3798344 [Abstract] [Full Text] [Related]
12. Kinetics of natural killer cell cytotoxicity during the graft-versus-host reaction. Relationship between natural killer cell activity, T and B cell activity, and development of histopathological alterations. Ghayur T, Seemayer TA, Lapp WS. Transplantation; 1987 Aug; 44(2):254-60. PubMed ID: 3498241 [Abstract] [Full Text] [Related]
13. Antileukemia activity of a natural killer cell line against human leukemias. Yan Y, Steinherz P, Klingemann HG, Dennig D, Childs BH, McGuirk J, O'Reilly RJ. Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753 [Abstract] [Full Text] [Related]
14. [Effect of hepatitis B virus C protein on function of natural killer cell in NK-92 cells]. Liu YX, Wei XH, Li B, Luo ZX, Xie JJ, Tan Y, Long SJ, Zhou BP. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Aug; 22(4):275-7. PubMed ID: 19105342 [Abstract] [Full Text] [Related]
15. Defective NK cell activity following thermal injury. Klimpel GR, Herndon DN, Fons M, Albrecht T, Asuncion MT, Chin R, Stein MD. Clin Exp Immunol; 1986 Nov; 66(2):384-92. PubMed ID: 3493101 [Abstract] [Full Text] [Related]
17. Cellular and humoral immune reactions in chronic active liver disease. II. Lymphocyte subsets and viral antigens in liver biopsies of patients with acute and chronic hepatitis B. Eggink HF, Houthoff HJ, Huitema S, Wolters G, Poppema S, Gips CH. Clin Exp Immunol; 1984 Apr; 56(1):121-8. PubMed ID: 6713726 [Abstract] [Full Text] [Related]
18. Blood T and B cells in patients with acute viral hepatitis A, B and non-A non-B. Cargnel A, Rumi MG, Cambieri R, Viganò P, Cancellieri V, Colombo M. Boll Ist Sieroter Milan; 1982 Apr; 61(5):375-82. PubMed ID: 6821443 [Abstract] [Full Text] [Related]
19. Differential effects of interferon-alpha 2 and interleukin-2 on natural killer cell activity in patients with acquired immune deficiency syndrome. Reddy MM, Chinoy P, Grieco MH. J Biol Response Mod; 1984 Aug; 3(4):379-86. PubMed ID: 6332880 [Abstract] [Full Text] [Related]